![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Preinitiation |
Unique ID issued by UMIN | UMIN000042921 |
Receipt No. | R000048903 |
Scientific Title | Measurement of salivary pH while chewing gum containing acidulant. -2 step crossover single blind controlled trial- |
Date of disclosure of the study information | 2021/01/06 |
Last modified on | 2021/01/06 |
Basic information | ||
Public title | Measurement of salivary pH while chewing gum containing acidulant. | |
Acronym | Effect of gum acidulant on saliva pH. | |
Scientific Title | Measurement of salivary pH while chewing gum containing acidulant. -2 step crossover single blind controlled trial- | |
Scientific Title:Acronym | Measurement of salivary pH while chewing gum containing acidulant. | |
Region |
|
Condition | |||
Condition | Healthy volunteers | ||
Classification by specialty |
|
||
Classification by malignancy | Others | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To examine whether gum containing acidulant lowers salivary pH during chewing below 5.7. |
Basic objectives2 | Safety |
Basic objectives -Others | |
Trial characteristics_1 | Confirmatory |
Trial characteristics_2 | |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | Salivary pH |
Key secondary outcomes | Salivary weight |
Base | |
Study type | Interventional |
Study design | |
Basic design | Cross-over |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Single blind -investigator(s) and assessor(s) are blinded |
Control | Dose comparison |
Stratification | NO |
Dynamic allocation | NO |
Institution consideration | Institution is not considered as adjustment factor. |
Blocking | NO |
Concealment | Numbered container method |
Intervention | ||
No. of arms | 6 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | Single intake of the gum 1 containing acidulant. | |
Interventions/Control_2 | Single intake of the gum 2 containing acidulant. | |
Interventions/Control_3 | Single intake of the gum 3 containing acidulant. | |
Interventions/Control_4 | Single intake of the gum 4 containing acidulant. | |
Interventions/Control_5 | Single intake of the gum 5 containing acidulant. | |
Interventions/Control_6 | Single intake of the gum 6 containing acidulant. | |
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | 1) Males and females whose age is between 20 and 60 years old
2) Subjects who can prohibit themselves from taking alcohol on the day before trial 3) Subjects who can sleep enough on the day before trial and keep their regular conditions |
|||
Key exclusion criteria | 1) Female subjects who are pregnant or lactating, or intending to become pregnant during the study
2) Subjects who have the possibility of developing allergic symptoms by the test food 3) Subjects who have a fever or complain of illness 4) Subjects who have difficulty chewing gum ordinarily (80 times/min) 5) Subjects who have meal or snack within 1 hour before the trial starts 6) Subjects who have a potential of Sjogren's syndrome (whose salivary flow late is below 1 mL/min) |
|||
Target sample size | 20 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | LOTTE Co., Ltd. | ||||||
Division name | Central Laboratory Basic Research Department Health Science Section | ||||||
Zip code | 336-8601 | ||||||
Address | 3-1-1, Numakage, Minami-ku, Saitama | ||||||
TEL | 048-837-0170 | ||||||
okuyama_satoko@lotte.co.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | LOTTE Co., Ltd. | ||||||
Division name | Central Laboratory Health Basic Research Department Science Section | ||||||
Zip code | 336-8601 | ||||||
Address | 3-1-1, Numakage, Minami-ku, Saitama | ||||||
TEL | 048-837-0170 | ||||||
Homepage URL | |||||||
satou_shouta@lotte.co.jp |
Sponsor | |
Institute | LOTTE Co., Ltd. |
Institute | |
Department |
Funding Source | |
Organization | LOTTE Co., Ltd. |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Ethical Committee of Shiba Palace clinic |
Address | DaiwaA Hamamatsucho Building 6F, 1-9-10 Hamamatsucho, Minato-ku, Tokyo |
Tel | 03-5408-1590 |
jimukyoku@mail.souken-r.com |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 株式会社ロッテ中央研究所(埼玉県) |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Preinitiation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048903 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |